Company Filing History:
Years Active: 1994
Title: Ingegred Hellstrom: Innovator in Chimeric Antibody Technology
Introduction
Ingegred Hellstrom is a notable inventor based in Seattle, WA. He has made significant contributions to the field of biotechnology, particularly in the development of chimeric antibodies. His work focuses on creating innovative solutions for targeting human tumor antigens.
Latest Patents
Ingegred Hellstrom holds a patent for a chimeric antibody with specificity to human tumor antigen. This invention involves a chimeric antibody that combines a human constant region with a murine variable region. It is specifically designed to target the human tumor antigen L6, mediating potent antibody-dependent cellular cytotoxicity against tumor target cells. This advancement has the potential to enhance cancer treatment methodologies.
Career Highlights
Hellstrom is associated with Bristol-Myers Squibb Company, where he continues to contribute to groundbreaking research in the field of oncology. His expertise in antibody technology has positioned him as a key figure in the development of therapeutic strategies aimed at combating cancer.
Collaborations
Ingegred has collaborated with esteemed colleagues such as Alvin Y Liu and Randy R Robinson. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the pursuit of medical advancements.
Conclusion
Ingegred Hellstrom's work in chimeric antibody technology represents a significant step forward in cancer treatment. His innovative approach and dedication to research continue to inspire advancements in the field of biotechnology.